Endocuff-assisted Versus Cap-assisted Versus Standard Colonoscopy

NCT ID: NCT02331836

Last Updated: 2019-02-12

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

COMPLETED

Clinical Phase

NA

Total Enrollment

561 participants

Study Classification

INTERVENTIONAL

Study Start Date

2015-02-28

Study Completion Date

2019-02-01

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

Comparison of Endocuff-assisted, Cap-assisted and Standard colonoscopy for assessment of the adenoma detection rate (ADR)

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

The Endocuff is a medical device, approved in 2012 by the American Food and Drug Administration, which was also authorized by the European Agency for the Evaluation of Medicinal Products. The aim of the cuff is to optimize the view of the colonic mucosa. There is also a transparent cap on the market, which is used in colonoscopy for a better evaluation of the mucosa and polyp detection. The goal of this project is to conduct a prospective randomized trial for clarification of the hypotheses, whether the usage of the Endocuff increases the detection rate of adenomas compared to the transparent cap or compared to standard colonoscopy.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Colorectal Polyps Colorectal Adenomas

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

FACTORIAL

Primary Study Purpose

DIAGNOSTIC

Blinding Strategy

SINGLE

Participants

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Arc Endocuff (AEC 110, 120, 130, 140)

Endocuff-assisted colonoscopy Colonoscopy with the Endocuff attached at the distal tip of the scope

Group Type ACTIVE_COMPARATOR

Arc Endocuff (AEC 110, 120, 130, 140)

Intervention Type DEVICE

Cap

Cap-assisted colonoscopy Colonoscopy with the transparent Cap attached at the distal tip of the scope

Group Type ACTIVE_COMPARATOR

Cap

Intervention Type DEVICE

Olympus Disposable distal attachment 15mm diameter, 4mm depth

Standard Colonoscope

Standard colonoscopy without any additional device

Group Type ACTIVE_COMPARATOR

Standard colonoscope

Intervention Type DEVICE

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Arc Endocuff (AEC 110, 120, 130, 140)

Intervention Type DEVICE

Cap

Olympus Disposable distal attachment 15mm diameter, 4mm depth

Intervention Type DEVICE

Standard colonoscope

Intervention Type DEVICE

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Colonoscopy independent from indication
* Age ≥ 18
* Patient is able to provide informed consent for the procedure

Exclusion Criteria

* Inflammatory Bowel Disease stenosis
* Pregnant of nursing patient
* Acute diverticulitis
* Active Inflammatory Bowel Disease
* Age ≤ 18
* Coagulation disorder (INR\>1.4 , Thrombocytes \< 50000/µl)
Minimum Eligible Age

18 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

No

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Helios Albert-Schweitzer-Klinik Northeim

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Tobias Meister

Prof. Dr. med. Tobias Meister

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Tobias Meister, Prof. Dr.med.

Role: PRINCIPAL_INVESTIGATOR

Helios Albert-Schweitzer-Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

University of Muenster

Münster, North Rhine-Westphalia, Germany

Site Status

University Medical Center Göttingen

Göttingen, , Germany

Site Status

HELIOS St. Marienberg Klinik Helmstedt

Helmstedt, , Germany

Site Status

HELIOS Albert-Schweitzer-Klinik

Northeim, , Germany

Site Status

HELIOS Medical Center Siegburg

Siegburg, , Germany

Site Status

Wroclaw Medical University

Wroclaw, , Poland

Site Status

Countries

Review the countries where the study has at least one active or historical site.

Germany Poland

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

EC-CUFF-2015

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

AI Colorectal Polyp Detection
NCT04979962 COMPLETED NA
Real Life AI in Polyp Detection
NCT04335318 COMPLETED NA